Qining Yang

Qining Yang

Auto-generated profile, based on publicly available information

Qining Yang

Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YZYukun Zhang
Yukun Zhang
CWChangyuan Wang
Changyuan Wang
YJYue Jin
Yue Jin
QYQining Yang
Qining Yang
QMQiang Meng
Qiang Meng
HShuijun sun
huijun sun
Catalpol, an iridoid glucoside, has been found present in large quantities in the root of Rehmannia glutinosa L. and showed a strong antioxidant capacity in the previous study. In the present work, the protective effect of catalpol against AS via inhibiting oxidative stress, DNA damage, and telomere shortening was found in LDLr−/− mice. This study also shows that activation of the peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α)/telomerase reverse transcriptase (TERT) pathway, which is the new link between mitochondria and telomere, was involved in the protective effects of catalpol. Further, by using PGC‐1α or TERT siRNA in oxLDL‐treated macrophages, it is proved that catalpol reduced oxidative stress, telomere function, and related DNA damage at least partly through activating the PGC‐1α/TERT pathway. Moreover, dual luciferase activity assay‐validated catalpol directly enhanced PGC‐1α promoter activity. In conclusion, our study revealed that the PGC‐1α/TERT pathway might be a possible therapeutic target in AS and catalpol has highly favorable characteristics for the treatment of AS via modulating this pathway.